Cargando…
Suppression of human papillomavirus type 16 E5 oncoprotein: A promising step in fostering the treatment of cervical cancer
Cervical cancer is a growing global disease in developing countries. Persistent infection with human papillomaviruses (HPV) is an essential causative agent in this type of cancer. Several studies demonstrate HPV E5 oncoprotein can impress the normal life cycle of HPV-infected cells by targeting some...
Autores principales: | HEMMAT, NIMA, DOUSTVANDI, MOHAMMAD AMIN, ASADZADEH, ZAHRA, MOKHTARZADEH, AHAD, BARADARAN, BEHZAD, BAGHI, HOSSEIN BANNAZADEH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207959/ https://www.ncbi.nlm.nih.gov/pubmed/37305401 http://dx.doi.org/10.32604/or.2022.023346 |
Ejemplares similares
-
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer
por: AGHBASH, PARISA SHIRI, et al.
Publicado: (2023) -
siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy
por: Shiri Aghbash, Parisa, et al.
Publicado: (2023) -
Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials
por: Oroojalian, Fatemeh, et al.
Publicado: (2020) -
Human papillomavirus E5 protein, the undercover culprit of tumorigenesis
por: Hemmat, Nima, et al.
Publicado: (2018) -
Neutrophils, Crucial, or Harmful Immune Cells Involved in Coronavirus Infection: A Bioinformatics Study
por: Hemmat, Nima, et al.
Publicado: (2020)